Cormorant Asset Management’s Forward Pharma A/S American Depositary Shares FWP Stock Holding History

Cormorant Asset Management’s Portfolio FWP Stock Details FWP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-84,168	Closed	-$12.7M	–	83
2017 Q1	$12.7M	Buy	84,168 +35,714	+74%	+$6.73M	1.84%	22
2016 Q4	$5.09M	Hold	48,454	–	–	0.69%	41
2016 Q3	$7.12M	Hold	48,454	–	–	0.79%	42
2016 Q2	$6.16M	Buy	48,454 +587	+1%	+$79.2K	0.87%	39
2016 Q1	$5.7M	Hold	47,867	–	–	0.86%	39
2015 Q4	$6.37M	Hold	47,867	–	–	0.76%	41
2015 Q3	$7.89M	Buy	47,867 +11,438	+31%	+$2.4M	1.26%	29
2015 Q2	$9.7M	Hold	36,429	–	–	1.29%	27
2015 Q1	$7.22M	Buy	36,429 +15,000	+70%	+$2.43M	1.12%	28
2014 Q4	$3.13M	Buy	+21,429	New	+$3.09M	0.48%	49

Other funds holding FWP

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

AIM

Assured Investment Management New York $79.5M AUM 115.55% 1-Year Est. Return

SAM

Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

RPAM

Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

FIM

Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

HCMT

Highland Capital Management (Texas) Dallas, Texas $39M AUM

Cormorant Asset Management's FWP Position: Q2 2017 in Review

Cormorant Asset Management sold out of Forward Pharma A/S American Depositary Shares (FWP) in Q2 2017, closing a stake of 84,168 shares — an estimated $12.7M sold.

Cormorant Asset Management first reported a position in FWP in Q4 2014 and held it in 10 quarters. The position peaked at $12.7M in Q1 2017. 24 funds tracked by Wall St. Rank hold FWP as of Q2 2017.

Cormorant Asset Management reported no remaining Forward Pharma A/S American Depositary Shares position as of Q2 2017 after selling out during the quarter.
Cormorant Asset Management sold 84,168 Forward Pharma A/S American Depositary Shares shares in Q2 2017, an estimated $12.7M.
Cormorant Asset Management first reported a position in Forward Pharma A/S American Depositary Shares in Q4 2014 and held it in 10 quarters.
Cormorant Asset Management's Forward Pharma A/S American Depositary Shares position peaked at $12.7M in Q1 2017.
24 funds tracked by Wall St. Rank held Forward Pharma A/S American Depositary Shares as of Q2 2017.

Based on Cormorant Asset Management's 13F filing for Q2 2017, filed 14 Aug 2017.